Breast cancer patients to have further NICE approved drug combination option on Cancer Drugs Fund

17 July 2019 - Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on ...

Read more →

Trump abandons drug pricing proposal that would have ended certain drug rebates

11 July 2019 - The Trump administration on Wednesday abandoned one of its signature drug-pricing efforts: a ban on many ...

Read more →

How Australia could almost eradicate H.I.V. transmissions

10 July 2019 - It took universal health care, political will and a health campaign designed to terrify the public, ...

Read more →

Decision for funding in the neurology, immunosuppression, diabetes and anti-thrombotic therapy areas

11 July 2019 - PHARMAC is pleased to announce the approval of a decision relating to medicines in the neurology, ...

Read more →

Neurocrine Biosciences announces FDA acceptance of new drug application for opicapone as an adjunctive treatment for patients with Parkinson's disease

10 July 2019 - New drug application based on data from 38 clinical studies, including two Phase III studies, with more ...

Read more →

Health Canada has authorised Vyvanse (lisdexamphetamine dimesylate), the first and only, chewable tablet for the treatment of attention deficit/hyperactivity disorder

10 July 2019 - Vyvanse offers an additional option for patients who prefer the convenience of a chewable tablet, or who ...

Read more →

Health Canada approves Pomalyst-based triplet combination for patients with multiple myeloma

10 July 2019 - Pomalyst in combination with bortezomib and dexamethasone, provides a new medication option for patients living with multiple ...

Read more →

Reforming the Orphan Drug Act for the 21st century

11 July 2019 - The pharmaceutical market has undergone radical changes, including markedly increased prices for rare-disease drugs.  ...

Read more →

Horizon Therapeutics submits teprotumumab biologics license application for the treatment of active thyroid eye disease

10 July 2019 - Horizon Therapeutics announced today that it has submitted a biologics license application to the U.S. FDA ...

Read more →

Canada’s labour leaders encourage premiers to embrace universal pharmacare

10 July 2019 - The presidents of federations of labour from across the country are in Saskatoon during the Council ...

Read more →

Biomarker-based cancer diagnostics: German pricing regulator sets high validation and reimbursement standards for novel diagnostic methods

10 July 2019 - On 20 June 2019, for the first time, the German Federal Joint Committee (G-BA), made the resolution ...

Read more →

FDA announces new efforts to expedite generic drug development and marketing to improve patient access to medicines

10 July 2019 - Today, the U.S. FDA announced a draft guidance, Harmonizing Compendial Standards With Drug Application Approval Using the ...

Read more →

A Supreme Court ruling may have made it harder to get some info from the FDA

9 July 2019 - Anyone seeking certain information about a medicine from the FDA may have a harder time getting ...

Read more →

GOP senators raise concerns over potential deal to lower drug prices

9 July 2019 - Republican Senators and Trump administration officials met Tuesday morning to debate a potential deal to lower ...

Read more →

U.S. appeals court signals sympathy to bid to strike down Obamacare

9 July 2019 - A federal appeals court panel appeared sympathetic on Tuesday to Republican efforts to overturn Obamacare, expressing skepticism ...

Read more →

New committee brings diverse patient, family, and caregiver voices to CADTH

10 July 2019 - Following a nationwide call for nominations, CADTH is pleased to announce the membership of its new ...

Read more →